Vaccines, Blood & Biologics
CBER FY 2011 Recall Postings
Class I recall: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
Class II recall: a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Class III recall: a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
Allergenic | Blood | Blood Deriv. | Device | IVD | Source Plasma | Therapeutic | Tissue | Vaccine | Total Events by Class | |
---|---|---|---|---|---|---|---|---|---|---|
Class I | 2 | 2 | ||||||||
Class II | 2 | 874 | 2 | 11 | 109 | 7 | 1,005 | |||
Class III | 1 | 231 | 1 | 2 | 2 | 132 | 4 | 373 | ||
Mixed Class (Cl. I/II) | 1 | 1 | ||||||||
Mixed Class (Cl. I/III) | ||||||||||
Mixed Class (Cl. II/III) | 125 | 2 | 127 | |||||||
Total Events by Product | 3 | 1,230 | 3 | 13 | 2 | 241 | 16 | 1,508 |
Direct Recall Classification (DRC) Related Data 2011:
Number of AI Requests during FY11 | 804 |
Number of Alerts to Possible Recall sent during FY 11 | 156 |
Number of DRC Recalls Classifed during FY 11 | 787 |